IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Eris Lifesciences IPO listing price is ₹ 601.05, issue price is ₹ 603.00, and currently trading at ₹ 1694.60 as on August 7, 2025. Eris Lifesciences IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Eris Lifesciences IPO is a Book Building listing on BSE,NSE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Axis Capital , Citigroup Global Markets India , Credit Suisse Securities (India) are the merchant bankers of Eris Lifesciences IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 8th February 2017.
Eris Lifesciences IPO offer price is ₹ 603.00 and got listed at ₹ 601.05. Read Eris Lifesciences IPO details mentioned above.The IPO of Eris Lifesciences Limited was listed on 29th June 2017. As of today, Eris Lifesciences IPO is trading at ₹ 1694.60, compared to the previous day’s close of ₹ 1724.80. Read the report above for detailed IPO performance.
The issue price of Eris Lifesciences IPO was ₹ 603.00 per equity share.
Eris Lifesciences IPO was listed at ₹601.05 on the stock exchange on 29th June 2017. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of August 7, 2025, the current market price of Eris Lifesciences IPO is ₹ 1694.60.
The 52-week high for Eris Lifesciences IPO is ₹ 1910.00, while the 52-week low is ₹ 1051.05. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Eris Lifesciences IPO listed at ₹ 601.05 against the issue price of ₹ 603.00 per equity share, showing a listing day gain/loss of -1.95 (-0.32%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Eris Lifesciences IPO stock moved from its listing price of ₹ 601.05 to the current price of ₹1694.60 per equity share, reflecting a change of 181.94% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Eris Lifesciences IPO issue date of 29th June 2017 and CMP of ₹1694.60, the estimated CAGR is approximately 13.58%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 1
Issue
Price :
₹ 603.00
Listing Price :
₹ 601.05
Previous Day Closing
₹ 1724.80
Eris Lifesciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Eris Lifesciences Financial Review Page
Merchant Banker(s) of Eris Lifesciences IPO: Axis Capital Limited , Citigroup Global Markets India Private Limited , Credit Suisse Securities (India) Private Limited
Eris Lifesciences IPO subscription was 3.29 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Eris Lifesciences IPO listed at a listing price of 601.05 against the offer price of 603.00.
The current market price of Eris Lifesciences is 1694.60.
Why Us?
